drugset / Trial / NCT00110929
Treatment for Patients With Secondary Hyperparathyroidism of End-Stage Renal Disease (ESRD)
RandomizedSingle-groupOpen-labelTreatment
Summary
The purpose of this research is to study the efficacy and safety of AMG 073 in patients with kidney failure who are being treated with hemodialysis or peritoneal dialysis and who also have secondary hyperparathyroidism (HPT).
Timeline
- Start
- 2002-11
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cinacalcet | Other / unclassified | — | Oral |